| Ident. | Authors (with country if any) | Title |
|---|
| 004B19 |
D. Dressler [Royaume-Uni] ; G. Dirnberger [Royaume-Uni] ; K. P. Bhatia [Royaume-Uni] ; A. Irmer [Allemagne] ; N. P. Quinn [Royaume-Uni] ; H. Bigalke [Allemagne] ; C. D. Marsden [Royaume-Uni] | Botulinum toxin antibody testing: Comparison between the mouse protection assay and the mouse lethality assay |
| 004B89 |
D. Dressier [Royaume-Uni] ; G. Dirnberger [Royaume-Uni] ; K. P. Bhatia [Royaume-Uni] ; A. Irmer [Allemagne] ; N. P. Quinn [Royaume-Uni] ; H. Bigalke [Allemagne] ; C. D. Marsden [Royaume-Uni] | Botulinum toxin antibody testing : Comparison between the mouse protection assay and the mouse lethality assay |
| 004F44 |
Dressler [Royaume-Uni] ; T. Scaravilli [Royaume-Uni] ; K. P. Bhatia [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Nicotine nasal spray is not reliable treatment for blepharospasm: Results of a pilot study |
| 005134 |
D. Dressler [Royaume-Uni] ; T. Scaravilli [Royaume-Uni] ; K. P. Bhatia [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Nicotine nasal spray is not reliable treatment for blepharospasm : Results of a pilot study |
| 005147 |
E. D. Playford [Royaume-Uni] ; R. E. Passingham [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; D. J. Brooks [Royaume-Uni] | Increased activation of frontal areas during arm movement in idiopathic torsion dystonia |
| 005155 |
M. G. Hanna [Royaume-Uni] ; M. B. Davis [Royaume-Uni] ; M. G. Sweeney [Royaume-Uni] ; M. Noursadeghi [Royaume-Uni] ; C. J. Ellis [Royaume-Uni] ; P. Elliot [Royaume-Uni] ; N. W. Wood [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Generalized chorea in two patients harboring the Friedreich's ataxia gene trinucleotide repeat expansion |
| 005241 |
Werhahn [Royaume-Uni, Allemagne] ; Brown [Royaume-Uni] ; P. D. Thompson [Royaume-Uni, Australie] ; C. D. Marsden [Royaume-Uni] | The clinical features and prognosis of chronic posthypoxic myoclonus |
| 005290 |
Anastasopoulos [Grèce, Royaume-Uni] ; K. Bhatia [Royaume-Uni] ; A. Bisdorff [Royaume-Uni] ; A. M. Bronstein [Royaume-Uni] ; M. A. Gresty [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Perception of spatial orientation in spasmodic torticollis part I: The postural vertical |
| 005306 |
M. Gu [Royaume-Uni] ; M. T. Gash [Royaume-Uni] ; J. M. Cooper [Royaume-Uni] ; G. K. Wenning [Royaume-Uni] ; S. E. Daniel [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; Schapira [Royaume-Uni] | Mitochondrial respiratory chain function in multiple system atrophy |
| 005394 |
Brown [Royaume-Uni] ; J. C. Rothwell [Royaume-Uni] ; J. M. Stevens [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Cerebellar axial postural tremor |
| 005452 |
K. J. Werhahn [Royaume-Uni] ; P. Brown [Royaume-Uni] ; P. D. Thompson [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | The clinical features and prognosis of chronic posthypoxic myoclonus |
| 005459 |
P. Brown [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] ; D. Barnes [Royaume-Uni] ; D. R. Wren [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Spinal rigidity following acute myelitis |
| 005477 |
D. Anastasopoulos [Grèce, Royaume-Uni] ; K. Bhatia [Royaume-Uni] ; A. Bisdorff [Royaume-Uni] ; A. M. Bronstein [Royaume-Uni] ; M. A. Gresty [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Perception of spatial orientation in spasmodic torticollis part I: The postural vertical |
| 005478 |
K. P. Bhatia [Royaume-Uni] ; V. L. Soland [Royaume-Uni] ; M. H. Bhatt [Inde] ; N. P. Quinn [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Paroxysmal exercise-induced dystonia : Eight new sporadic cases and a review of the literature |
| 005532 |
P. Brown [Royaume-Uni] ; J. C. Rothwell [Royaume-Uni] ; J. M. Stevens [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Cerebellar axial postural tremor |
| 005565 |
Quirk [Royaume-Uni] ; G. L. Sheean [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Treatment of nonoccupational limb and trunk dystonia with botulinum toxin |
| 005582 |
G. K. Wenning [Royaume-Uni] ; R. Granata [Italie] ; P. M. Laboyrie ; N. P. Quinn [Royaume-Uni] ; Jenner ; C. D. Marsden [Royaume-Uni] | Reversal of behavioural abnormalities by fetal allografts in a novel rat model of striatonigral degeneration |
| 005599 |
B. Zeng [Royaume-Uni] ; Jenner [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Partial reversal of increased preproenkephalin messenger ribonucleic acid (mRNA) and decreased preprotachykinin mRNA by foetal dopamine cells in unilateral 6‐Hydroxydopamine–Lesioned rat striatum parallels functional recovery |
| 005688 |
Kullmann [Royaume-Uni] ; R. S. Howard [Royaume-Uni] ; D. H. Miller [Royaume-Uni] ; N. P. Hirsh [Royaume-Uni] ; P. Brown [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Brainstem encephalopathy with stimulus‐sensitive myoclonus leading to respiratory arrest, but with recovery: A description of two cases and review of the literature |
| 005733 |
J. A. Quirk [Royaume-Uni] ; G. L. Sheean [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Treatment of nonoccupational limb and trunk dystonia with botulinum toxin |
| 005785 |
D. M. Kullmann [Royaume-Uni] ; R. S. Howard [Royaume-Uni] ; D. H. Miller [Royaume-Uni] ; N. P. Hirsch [Royaume-Uni] ; P. Brown [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Brainstem encephalopathy with stimulus-sensitive myoclonus leading to respiratory arrest, but with recovery : A description of two cases and review of the literature |
| 005809 |
W. Van Der Kamp [Royaume-Uni] ; Rothwell [Royaume-Uni] ; P. D. Thompson [Royaume-Uni] ; B. L. Day [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | The movement‐related cortical potential is abnormal in patients with idiopathic torsion dystonia |
| 005849 |
Markus [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; G. Lennox [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; D. C. Costa [Royaume-Uni] | Patterns of regional cerebral blood flow in corticobasal degeneration studied using HMPAO SPECT; comparison with Parkinson's disease and normal controls |
| 005860 |
Haaxma [Pays-Bas] ; A. Van Boxtel [Pays-Bas] ; W. H. Brouwer [Pays-Bas] ; L. N. H. Goeken [Pays-Bas] ; J. J. Denier Van Der Gon [Pays-Bas] ; J. G. Colebatch [Royaume-Uni] ; A. Martin [Royaume-Uni] ; D. J. Brooks [Royaume-Uni] ; J. Noth [Allemagne] ; C. D. Marsden [Royaume-Uni] | Motor function in a patient with bilateral lesions of the globus pallidus |
| 005874 |
J. M. Cooper [Royaume-Uni] ; S. E. Daniel [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; Schapira [Royaume-Uni] | L‐Dihydroxyphenylalanine and complex I deficiency in Parkinson's disease brain |
| 005921 |
R. K. B. Pearce ; M. Jackson ; L. Smith ; Jenner ; C. D. Marsden [Royaume-Uni] | Chronic L‐DOPA administration induces dyskinesias in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐treated common marmoset (Callithrix jacchus) |
| 005992 |
H. S. Markus [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; G. Lennox ; C. D. Marsden ; D. C. Costa | Patterns of regional cerebral blood flow in corticobasal degeneration studies using HMPAO SPECT ; comparison with Parkinson's disease and normal controls |
| 005A03 |
J. M. Cooper [Royaume-Uni] ; S. E. Daniel ; C. D. Marsden ; A. H. V. Schapira [Royaume-Uni] | L-dihyroxyphenalanine and complex I deficiency in Parkinson's disease brain |
| 005A74 |
V. Planté-Bordeneuve [Royaume-Uni] ; M. B. Davis [Royaume-Uni] ; D. M. Maraganore [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; Harding [Royaume-Uni] | Tyrosine hydroxylase polymorphism in familial and sporadic Parkinson's disease |
| 005B09 |
Brown [Royaume-Uni] ; J. C. Rothwell [Royaume-Uni] ; P. D. Thompson [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Propriospinal myoclonus: Evidence for spinal “pattern” generators in humans |
| 005B56 |
Gilles Fénelon [France] ; Annaék Fève [France] ; Avindra Nath [Canada] ; Douglas E. Hobson [Canada] ; A. H. V. Schapira [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; M. S. Sandy [États-Unis] ; J. W. Langston [États-Unis] ; D. A. Di Monte [États-Unis] ; James J. Gaul [États-Unis] | Letters to the editor |
| 005B94 |
P. D. Thompson [Royaume-Uni] ; K. P. Bhatia [Royaume-Uni] ; P. Brown [Royaume-Uni] ; M. B. Davis [Royaume-Uni] ; M. Pires [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] ; P. Luthert [Royaume-Uni] ; M. Honovar [Royaume-Uni] ; M. D. O'Brien [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; Harding [Royaume-Uni] | Cortical myoclonus in huntington's disease |
| 005C02 |
S. Rose [Royaume-Uni] ; Jenner [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Chronic administration does not alter the accumulation of L‐dopa into muscle |
| 005C40 |
V. Plante-Bordeneuve [Royaume-Uni] ; M. B. Davis ; D. M. Maraganore ; C. D. Marsden ; A. E. Harding | Tyrosine hydroxylase polymorphism in familial and sporadic Parkinson's disease |
| 005C55 |
P. Brown [Royaume-Uni] ; J. C. Rothwell ; P. D. Thompson ; C. D. Marsden | Propriospinal myoclonus: evidence for spinal pattern generators in humans |
| 005C72 |
D. T. Dexter [Royaume-Uni] ; A. E. Holley ; W. D. Flitter ; T. F. Slater ; F. R. Wells ; S. E. Daniel ; Andrew Lees (neurologue) [Royaume-Uni] ; P. Jenner [Royaume-Uni] ; C. D. Marsden | Increated levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study |
| 005D25 |
S. B. Blunt [Royaume-Uni] ; Jenner ; C. D. Marsden [Royaume-Uni] | Suppressive effect of L‐dopa on dopamine cells remaining in the ventral tegmental area of rats previously exposed to the neurotoxin 6‐hydroxydopamine |
| 005D74 |
D. Conway [Royaume-Uni] ; P. G. Bain [Royaume-Uni] ; T. T. Warner [Royaume-Uni] ; M. B. Davis [Royaume-Uni] ; L. J. Findley [Royaume-Uni] ; P. D. Thompson [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; Harding [Royaume-Uni] | Linkage analysis with chromosome 9 markers in hereditary essential tremor |
| 005E68 |
K. Bhatia [Royaume-Uni] ; S. E. Daniel ; C. D. Marsden | Orofacial dystonia and rest tremor in a patient with normal brain pathology |
| 005F31 |
Gibb [Royaume-Uni] ; L. Kilford [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Severe generalised dystonia associated with a mosaic pattern of striatal gliosis |
| 006001 |
Robert E. Burke [États-Unis] ; N. A. Fletcher [Royaume-Uni] ; A. E. Harding [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; S. Moghal [Canada] ; A. H. Rajput [Canada] ; Andrew J. Hughes [Royaume-Uni] ; Susan E. Daniel [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; G. W. Thickbroom ; F. L. Mastaglia ; J. Artieda [Espagne] ; J. A. Obeso [Espagne] ; R. J. Hardie [Royaume-Uni] ; R. A. Morgan-Hughes [Royaume-Uni] | Letters to the Editor |
| 006004 |
H. Meierkord [Royaume-Uni] ; Fish [Royaume-Uni] ; S. J. M. Smith [Royaume-Uni] ; C. A. Scott [Royaume-Uni] ; S. D. Shorvon [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Is nocturnal paroxysmal dystonia a form of frontal lobe epilepsy? |
| 006006 |
Stocchi [Italie] ; S. Ruggieri [Italie] ; A. Carta [Italie] ; J. Ryatt [Royaume-Uni] ; N. Quinn [Royaume-Uni] ; P. Jenner [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; A. Agnoli [Italie] | Intravenous boluses and continuous infusions of L‐DOPA methyl ester in fluctuating patients with Parkinson's disease |
| 006015 |
Steiger [Royaume-Uni] ; M. Pires [Royaume-Uni] ; F. Scaravilli [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Hemiballism and chorea in a patient with parkinsonism due to a multisystem degeneration |
| 006066 |
W. R. G. Gibb [Royaume-Uni] ; L. Kilford ; C. D. Marsden | Severe generalised dystonia associated with a mosaic pattern of striatal gliosis |
| 006093 |
M. J. Steiger [Royaume-Uni] ; M. Pires ; F. Scaravilli ; N. P. Quinn ; C. D. Marsden | Hemiballism and chorea in a patient with parkinsonism due to a multisystem degeneration |
| 006124 |
M. J. Steiger [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Sickness due to levodopa‐induced neck dyskinesias in Parkinson's disease |
| 006129 |
J. S. Duncan [Royaume-Uni] ; P. Brown [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Progressive myoclonus and histidinaemia |
| 006141 |
M. J. Steiger [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] ; B. Toone [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Off‐period screaming accompanying motor fluctuations in Parkinson's disease |
| 006161 |
Fletcher [Royaume-Uni] ; A. E. Harding [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Intrafamilial correlation in idiopathic torsion dystonia |
| 006174 |
K. R. Nair [Inde] ; R. Bhaskaran [Inde] ; C. D. Marsden [Royaume-Uni] | Essential tremor associated with paroxysmal kinesigenic dystonia |
| 006205 |
Maraganore [Royaume-Uni] ; A. E. Harding [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | A clinical and genetic study of familial Parkinson's disease |
| 006206 |
Fletcher [Royaume-Uni] ; A. E. Harding [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | A case‐control study of idiopathic torsion dystonia |
| 006229 |
N. A. Fletcher [Royaume-Uni] ; A. E. Harding ; C. D. Marsden | Intrafamilial correlation in idiopathic torsion dystonia |
| 006248 |
N. A. Fletcher [Royaume-Uni] ; A. E. Harding ; C. D. Marsden | A case-control study of idiopathic torsion dystonia |
| 006298 |
Truong [Royaume-Uni, États-Unis] ; Harding [Royaume-Uni] ; F. Scaravilli [Royaume-Uni] ; S. J. M. Smith [Royaume-Uni] ; J. A. Morgan-Hughes [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Movement disorders in mitochondrial myopathies. A study of nine cases with two autopsy studies |
| 006300 |
Schapira [Royaume-Uni] ; I. J. Holt [Royaume-Uni] ; M. Sweeney [Royaume-Uni] ; A. E. Harding [Royaume-Uni] ; P. Jenner [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Mitochondrial DNA analysis in Parkinson's disease |
| 006310 |
F. Grandas [Espagne] ; N. Quinn [Royaume-Uni] ; J. Elston [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; Arthur S. Walters ; Wayne Hening ; Sudhansu Chokroverty ; Hisamasa Imai [Japon] ; Hirotaro Narabayashi [Japon] ; Niall Quinn [Royaume-Uni] ; C. David Marsden [Royaume-Uni] | Letters to the editor |
| 006348 |
Winer [Royaume-Uni] ; D. R. Fish [Royaume-Uni] ; D. Sawyers [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | A movement disorder as a presenting feature of recurrent hypoglycaemia |
| 006414 |
C. D. Marsden [Royaume-Uni] ; J. A. Obeso [Espagne] | Viewpoints on the Ramsay Hunt syndrome. The Ramsay Hunt syndrome is a useful clinical entity |
| 006422 |
Gibb [Royaume-Uni] ; M. Terruli [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; P. Jenner [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | The evolution and distribution of morphological changes in the nervous system of the common marmoset following the acute administration of 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine |
| 006424 |
Coleman [Royaume-Uni] ; K. W. Lange [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] ; A. E. Loper [États-Unis] ; J. V. Bondi [États-Unis] ; M. Hichens [États-Unis] ; S. M. Stahl [Royaume-Uni, États-Unis] ; C. D. Marsden [Royaume-Uni] | The antiparkinsonian actions and pharmacokinetics of transdermal (+)‐4‐Propyl‐9‐hydroxynaphthoxazine (+ PHNO): Preliminary results |
| 006435 |
N. P. Quinn ; P. Luthert ; M. Honavar ; C. D. Marsden [Royaume-Uni] | Pure akinesia due to lewy body Parkinson's disease: A case with pathology |
| 006476 |
J. A. Temlett [Suisse] ; N. P. Quinn [Royaume-Uni] ; P. G. Jenner [Suisse] ; C. D. Marsden [Royaume-Uni] ; E. Pourcher [France] ; A. Bonnet [France] ; Yves Agid [France] ; R. Markstein [Suisse] ; X. Lataste [Suisse] | Antiparkinsonian activity of CY 208–243, a partial D‐1 dopamine receptor agonist, in MPTP‐treated marmosets and patients with Parkinson's disease |
| 006493 |
W. R. G. Gibb ; M. Terruli ; Andrew Lees (neurologue) [Royaume-Uni] ; P. Jenner ; C. D. Marsden | The evolution and distribution of morphological changes in the nervous system of the common marmoset following the acute administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
| 006532 |
Gibb [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Pathological report of four patients presenting with cranial dystonias |
| 006537 |
Coleman [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Multiple sclerosis presenting as adult onset dystonia |
| 006552 |
Fletcher [Royaume-Uni] ; R. Stell [Royaume-Uni] ; A. E. Harding [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Degenerative cerebellar ataxia and focal dystonia |
| 006565 |
Brown [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | An investigation of the phenomenon of “set” in Parkinson's disease |
| 006576 |
W. R. G. Gibb ; Andrew Lees (neurologue) [Royaume-Uni] ; C. D. Marsden | Pathological report of four patients presenting with cranial dystonias |
| 006632 |
M. Nomoto [Royaume-Uni] ; P. D. Thompson [Royaume-Uni] ; M. P. Sheehy [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Anticholinergic‐induced chorea in the treatment of focal dystonia |
| 006681 |
Leenders [Royaume-Uni] ; R. S. J. Frackowiak [Royaume-Uni] ; N. Quinn [Royaume-Uni] ; D. Brooks [Royaume-Uni] ; D. Sumner [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Ipsilateral blepharospasm and contralateral hemidystonia and parkinsonism in a patient with a unilateral rostral brainstem– thalamic lesion: Structural and functional abnormalities studied with CT, MRI, and PET scanning |
| 006685 |
P. D. Thompson [Royaume-Uni] ; J. P. R. Dick [Royaume-Uni] ; B. L. Day [Royaume-Uni] ; J. C. Rothwell [Royaume-Uni] ; A. Berardelli [Royaume-Uni] ; T. Kachi [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Electrophysiology of the corticomotoneurone pathways in patients with movement disorders |
| 006697 |
Leenders [Royaume-Uni] ; R. S. J. Frackowiak [Royaume-Uni] ; N. Quinn [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Brain energy metabolism and dopaminergic function in Huntington's disease measured in vivo using positron emission tomography |
| 006701 |
J. Garvey [Royaume-Uni] ; M. Petersen ; C. M. Waters ; S. P. Rose [Royaume-Uni] ; S. Hunt ; R. Briggs ; P. Jenner [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Administration of MPTP to the common marmoset does not alter cortical cholinergic function |
